Suppr超能文献

原发性醛固酮增多症患者肾激肽酶的意义

Significance of renal kininases in patients with primary aldosteronism.

作者信息

Ura N, Shimamoto K, Nomura N, Iwata M, Aoyama T, Takagawa Y, Iimura O

机构信息

Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.

出版信息

Clin Exp Hypertens. 1995 Oct;17(7):1049-58. doi: 10.3109/10641969509033650.

Abstract

To elucidate the significance of renal kininases in primary aldosteronism (PA), urinary total kininase, kininase I, II and neutral endopeptidase 24.11 (NEP) were examined and evaluated for the regulation mechanisms of these kininases. Total kininase, kininase I and NEP were significantly higher in PA than in normotensives (NT), whereas no difference was found for kininase II. Moreover, 42% of total kininase consisted of unknown kininase(s), different from kininase I, II or NEP. There were significantly positive correlations between plasma aldosterone concentration and total kininase, kininase I and unknown kininase(s) in PA. After the adrenalectomy, urinary kininases decreased into normal ranges, and unknown kininase(s) were negligible. These findings suggested that: 1) kininase I and NEP are accelerated in PA; 2) unknown kininase(s) differing from kininase I, II or NEP may exist in PA; 3) mineralocorticoids may regulate renal kininases; and 4) accelerated renal kininases may play some role in disorders of the renal water-sodium metabolism and in high blood pressure in PA.

摘要

为阐明肾激肽酶在原发性醛固酮增多症(PA)中的意义,对尿总激肽酶、激肽酶I、激肽酶II和中性内肽酶24.11(NEP)进行了检测,并对这些激肽酶的调节机制进行了评估。PA患者的总激肽酶、激肽酶I和NEP显著高于血压正常者(NT),而激肽酶II无差异。此外,总激肽酶的42%由不同于激肽酶I、II或NEP的未知激肽酶组成。PA患者血浆醛固酮浓度与总激肽酶、激肽酶I和未知激肽酶之间存在显著正相关。肾上腺切除术后,尿激肽酶降至正常范围,未知激肽酶可忽略不计。这些发现提示:1)PA中激肽酶I和NEP活性增强;2)PA中可能存在不同于激肽酶I、II或NEP的未知激肽酶;3)盐皮质激素可能调节肾激肽酶;4)肾激肽酶活性增强可能在PA患者肾水钠代谢紊乱和高血压中起一定作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验